Multiple Cancer Signaling Pathways

Multiple Cancer Signaling Pathways refers to the integrated network of intracellular and extracellular communication routes that govern essential cellular functions such as growth, differentiation, and apoptosis. In the context of oncology, these pathways—including the PI3K/AKT/mTOR, MAPK/ERK, and JAK/STAT cascades—are often constitutively activated or dysregulated by genetic mutations, leading to the hallmarks of cancer [1][2]. Because cancer cells frequently utilize redundant pathways to bypass single-node inhibition, therapeutic strategies often involve multi-kinase inhibitors or combination therapies designed to hit multiple signaling nodes simultaneously [3]. This broad approach aims to reduce the likelihood of acquired resistance and enhance anti-tumor efficacy across various malignancies. However, targeting multiple pathways also increases the risk of systemic toxicity due to the inhibition of these same pathways in healthy tissues [3]. Consequently, Multiple Cancer Signaling Pathways serves as a conceptual framework for drug development rather than a specific, singular molecular target.

Other names

Oncogenic signaling networksCancer cell signaling cascadesIntracellular signaling pathways

Simultaneous inhibition of multiple signaling nodes and protein kinases across various oncogenic cascades to suppress tumor growth and survival.